<?xml version="1.0" encoding="UTF-8"?>
<term>
  <id>00485</id>
  <doi>10.1351/goldbook.A00485</doi>
  <code>A00485</code>
  <status>current</status>
  <longtitle>IUPAC Gold Book - asymmetric transformation</longtitle>
  <title>asymmetric transformation</title>
  <contains>deracemization</contains>
  <termversion>2.3.3</termversion>
  <lastupdated>2014-02-24</lastupdated>
  <definitions>
    <item>
      <id>1</id>
      <text>The conversion of a racemate into a pure enantiomer or into a mixture in which one enantiomer is present in excess, or of a diastereoisomeric mixture into a single diastereoisomer or into a mixture in which one diastereoisomer predominates. This is sometimes called deracemization. If the two enantiomers of a chiral substrate A are freely interconvertible and if an equal amount or excess of a non-racemizing second enantiomerically pure chemical species, say (R)-B, is added to a solution of racemic A, then the resulting equilibrium mixture of adducts A · B will, in general, contain unequal amounts of the diastereoisomers (R)-A · (R)-B and (S)-A · (R)-B. The result of this equilibration is called asymmetrictransformation of the first kind. If, in such a system, the two diastereoisomeric adducts differ considerably in solubility so that only one of them, say (R)-A · (R)-B, crystallizes from the solution, then the equilibration of diastereoisomers in solution and concurrent crystallization will continue so that all (or most) of the substrate A can be isolated as the crystalline diastereoisomer (R)-A · (R)-B. Such a 'crystallization-induced asymmetrictransformation' is called an asymmetrictransformation of the second kind.</text>
      <links>
        <item>
          <title>stereoconvergence</title>
          <url>https://goldbook.iupac.org/terms/view/S05975</url>
        </item>
        <item>
          <title>stereoconvergence</title>
          <url>https://goldbook.iupac.org/terms/view/S05975</url>
        </item>
        <item>
          <title>racemate</title>
          <url>https://goldbook.iupac.org/terms/view/R05025</url>
        </item>
        <item>
          <title>enantiomer</title>
          <url>https://goldbook.iupac.org/terms/view/E02069</url>
        </item>
        <item>
          <title>racemic</title>
          <url>https://goldbook.iupac.org/terms/view/R05026</url>
        </item>
        <item>
          <title>equilibration</title>
          <url>https://goldbook.iupac.org/terms/view/E02175</url>
        </item>
        <item>
          <title>asymmetric</title>
          <url>https://goldbook.iupac.org/terms/view/A00478</url>
        </item>
        <item>
          <title>transformation</title>
          <url>https://goldbook.iupac.org/terms/view/T06446</url>
        </item>
        <item>
          <title>solubility</title>
          <url>https://goldbook.iupac.org/terms/view/S05740</url>
        </item>
        <item>
          <title>crystallization</title>
          <url>https://goldbook.iupac.org/terms/view/C01434</url>
        </item>
        <item>
          <title>stereoconvergence</title>
          <url>https://goldbook.iupac.org/terms/view/S05975</url>
        </item>
        <item>
          <title>racemate</title>
          <url>https://goldbook.iupac.org/terms/view/R05025</url>
        </item>
        <item>
          <title>enantiomer</title>
          <url>https://goldbook.iupac.org/terms/view/E02069</url>
        </item>
        <item>
          <title>racemic</title>
          <url>https://goldbook.iupac.org/terms/view/R05026</url>
        </item>
        <item>
          <title>equilibration</title>
          <url>https://goldbook.iupac.org/terms/view/E02175</url>
        </item>
        <item>
          <title>asymmetric</title>
          <url>https://goldbook.iupac.org/terms/view/A00478</url>
        </item>
        <item>
          <title>transformation</title>
          <url>https://goldbook.iupac.org/terms/view/T06446</url>
        </item>
        <item>
          <title>solubility</title>
          <url>https://goldbook.iupac.org/terms/view/S05740</url>
        </item>
        <item>
          <title>crystallization</title>
          <url>https://goldbook.iupac.org/terms/view/C01434</url>
        </item>
        <item>
          <title>diastereoisomeric</title>
          <url>https://goldbook.iupac.org/terms/view/D01679</url>
        </item>
        <item>
          <title>chiral</title>
          <url>https://goldbook.iupac.org/terms/view/C01057</url>
        </item>
      </links>
      <sources>
        <item>PAC, 1996, 68, 2193. 'Basic terminology of stereochemistry (IUPAC Recommendations 1996)' on page 2200 (https://doi.org/10.1351/pac199668122193)</item>
      </sources>
    </item>
  </definitions>
  <links>
    <html>https://goldbook.iupac.org/terms/view/A00485/html</html>
    <json>https://goldbook.iupac.org/terms/view/A00485/json</json>
    <xml>https://goldbook.iupac.org/terms/view/A00485/xml</xml>
    <plain>https://goldbook.iupac.org/terms/view/A00485/plain</plain>
  </links>
  <citation>Citation: 'asymmetric transformation' in IUPAC Compendium of Chemical Terminology, 5th ed. International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.A00485</citation>
  <license>The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International (https://creativecommons.org/licenses/by-sa/4.0/) for individual terms.</license>
  <collection>If you are interested in licensing the Gold Book for commercial use, please contact the IUPAC Executive Director at executivedirector@iupac.org .</collection>
  <disclaimer>The International Union of Pure and Applied Chemistry (IUPAC) is continuously reviewing and, where needed, updating terms in the Compendium of Chemical Terminology (the IUPAC Gold Book). Users of these terms are encouraged to include the version of a term with its use and to check regularly for updates to term definitions that you are using.</disclaimer>
  <accessed>2025-02-25T07:01:00+00:00</accessed>
</term>
